Mobile

A Phase 2, Multicenter, Open-Label Extension (OLE) Study to Observe the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of ABT 494 in Subjects with Crohn's Disease

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-003759-23

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To observe the long-term efficacy, safety, and tolerability of repeated administration of ABT-494 in subjects with Crohn's disease (CD) who completed Study M13-740.

Critère d'inclusion

  • Crohn’s Disease

Liens